Ernexa Therapeutics (ERNAW) Shares Outstanding (Diluted Average) (2010 - 2026)

Ernexa Therapeutics has reported Shares Outstanding (Diluted Average) for 11 years, with the latest figure at $792000.0 in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 457.75% year-over-year to $792000.0; the trailing twelve-month figure through Mar 2026 stood at $792000.0 (up 457.75% YoY), and the FY2025 full-year result was $6.3 million, up 593.08% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $792000.0, down from $6.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $6.3 million in Q4 2025, with the low at $142000.0 in Q1 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $3.3 million across 5 years, with a median of $3.1 million in 2022.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) surged 9544.23% — and 2025, when it tumbled 97.38%.
• Ernexa Therapeutics' Shares Outstanding (Diluted Average) stood at $3.1 million in 2022, then soared by 74.17% to $5.3 million in 2023, then slumped by 82.88% to $910000.0 in 2024, then surged by 593.08% to $6.3 million in 2025, then tumbled by 87.44% to $792000.0 in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $792000.0 (Q1 2026), $6.3 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.